These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9747815)

  • 1. Predictive factors for late toxicity after endobronchial brachytherapy: a multivariate analysis.
    Hennequin C; Tredaniel J; Chevret S; Durdux C; Dray M; Manoux D; Perret M; Bonnaud G; Homasson JP; Chotin G; Hirsch A; Maylin C
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):21-7. PubMed ID: 9747815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High-dose rate endobronchial brachytherapy: results and complications in 189 patients].
    Taulelle M; Chauvet B; Vincent P; Félix-Faure C; Bucciarelli B; Garcia R; Reboul F
    Bull Cancer Radiother; 1996; 83(3):127-34. PubMed ID: 8977562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of roentgenographically occult endobronchial carcinoma with external beam radiotherapy and intraluminal low-dose-rate brachytherapy: second report.
    Saito M; Yokoyama A; Kurita Y; Uematsu T; Tsukada H; Yamanoi T
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):673-80. PubMed ID: 10837951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary radiotherapy with endobronchial high-dose-rate brachytherapy boost for inoperable lung cancer: long-term results.
    Rochet N; Hauswald H; Stoiber EM; Hensley FW; Becker HD; Debus J; Lindel K
    Tumori; 2013; 99(2):183-90. PubMed ID: 23748812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic malignancies.
    Gustafson G; Vicini F; Freedman L; Johnston E; Edmundson G; Sherman S; Pursel S; Komic M; Chen P; Borrego JC
    Cancer; 1995 May; 75(9):2345-50. PubMed ID: 7712446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endobronchial brachytherapy: technique and indications].
    Hennequin C; Bleichner O; Trédaniel J; Maylin C
    Cancer Radiother; 2003 Feb; 7(1):33-41. PubMed ID: 12648715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for massive hemoptysis after endobronchial brachytherapy in patients with tracheobronchial malignancies.
    Hara R; Itami J; Aruga T; Kozuka T; Nakajima K; Yamashita H; Uno T; Morita T; Itoh H; Nomura T
    Cancer; 2001 Nov; 92(10):2623-7. PubMed ID: 11745197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer.
    Kubaszewska M; Skowronek J; Chicheł A; Kanikowski M
    Neoplasma; 2008; 55(3):239-45. PubMed ID: 18348661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study.
    Pérol M; Caliandro R; Pommier P; Malet C; Montbarbon X; Carrie C; Ardiet JM
    Chest; 1997 May; 111(5):1417-23. PubMed ID: 9149603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor?
    Langendijk JA; Tjwa MK; de Jong JM; ten Velde GP; Wouters EF
    Radiother Oncol; 1998 Nov; 49(2):175-83. PubMed ID: 10052884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local determinants of response to endobronchial high-dose rate brachytherapy in bronchogenic carcinoma.
    Ofiara L; Roman T; Schwartzman K; Levy RD
    Chest; 1997 Oct; 112(4):946-53. PubMed ID: 9377957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intrabronchial curietherapy. Experiences at Hôpital Saint-Louis after the treatment of 149 patients].
    Trédaniel J; Hennequin C; Zalcman G; Gossot D; Lavergne F; Colin P; Manoux D; Perret M; Gerber F; Maylin C; Hirsch A
    Rev Mal Respir; 1997 Dec; 14(6):465-72. PubMed ID: 9496605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose-rate intraluminal irradiation in bronchogenic carcinoma. Technique and results.
    Nori D; Allison R; Kaplan B; Samala E; Osian A; Karbowitz S
    Chest; 1993 Oct; 104(4):1006-11. PubMed ID: 7691481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension.
    Gejerman G; Mullokandov EA; Bagiella E; Blaivas A; Beitler JJ
    Brachytherapy; 2002; 1(4):204-10. PubMed ID: 15062168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irradiated volume and the risk of fatal hemoptysis in patients submitted to high dose-rate endobronchial brachytherapy.
    Carvalho Hde A; Gonçalves SL; Pedreira W; Gregório MG; de Castro I; Aisen S
    Lung Cancer; 2007 Mar; 55(3):319-27. PubMed ID: 17129634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical benefits of the low dose rate endobronchial irradiation of malignant airway obstructions.
    Spásová I; Petera J
    Neoplasma; 2001; 48(3):234-40. PubMed ID: 11583295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer.
    Anacak Y; Mogulkoc N; Ozkok S; Goksel T; Haydaroglu A; Bayindir U
    Lung Cancer; 2001 Nov; 34(2):253-9. PubMed ID: 11679184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.
    Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y
    Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endobronchial brachytherapy: the Saint-Louis Hospital experience].
    Hennequin C; Trédaniel J; Durdux C; Zalcman G; Dray M; Manoux D; Perret M; Housset M; Hirsch A; Maylin C
    Cancer Radiother; 1997; 1(2):159-64. PubMed ID: 9273188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of high dose rate (HDR) brachytherapy in advanced non-small cell lung cancer].
    Makarewicz R
    Pneumonol Alergol Pol; 2002; 70(5-6):265-77. PubMed ID: 12518625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.